Anti-CCN5/ CT58/ CTGF-L functional antibody

Anti-CCN5/ CT58/ CTGF-L functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CCN5/CCN5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0753-Ab-1/ GM-Tg-hg-SE0753-Ab-2Anti-Human CCN5 monoclonal antibodyHuman
GM-Tg-rg-SE0753-Ab-1/ GM-Tg-rg-SE0753-Ab-2Anti-Rat CCN5 monoclonal antibodyRat
GM-Tg-mg-SE0753-Ab-1/ GM-Tg-mg-SE0753-Ab-2Anti-Mouse CCN5 monoclonal antibodyMouse
GM-Tg-cynog-SE0753-Ab-1/ GM-Tg-cynog-SE0753-Ab-2Anti-Cynomolgus/ Rhesus macaque CCN5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0753-Ab-1/ GM-Tg-felg-SE0753-Ab-2Anti-Feline CCN5 monoclonal antibodyFeline
GM-Tg-cang-SE0753-Ab-1/ GM-Tg-cang-SE0753-Ab-2Anti-Canine CCN5 monoclonal antibodyCanine
GM-Tg-bovg-SE0753-Ab-1/ GM-Tg-bovg-SE0753-Ab-2Anti-Bovine CCN5 monoclonal antibodyBovine
GM-Tg-equg-SE0753-Ab-1/ GM-Tg-equg-SE0753-Ab-2Anti-Equine CCN5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0753-Ab-1/ GM-Tg-hg-SE0753-Ab-2; GM-Tg-rg-SE0753-Ab-1/ GM-Tg-rg-SE0753-Ab-2;
GM-Tg-mg-SE0753-Ab-1/ GM-Tg-mg-SE0753-Ab-2; GM-Tg-cynog-SE0753-Ab-1/ GM-Tg-cynog-SE0753-Ab-2;
GM-Tg-felg-SE0753-Ab-1/ GM-Tg-felg-SE0753-Ab-2; GM-Tg-cang-SE0753-Ab-1/ GM-Tg-cang-SE0753-Ab-2;
GM-Tg-bovg-SE0753-Ab-1/ GM-Tg-bovg-SE0753-Ab-2; GM-Tg-equg-SE0753-Ab-1/ GM-Tg-equg-SE0753-Ab-2
Products NameAnti-CCN5 monoclonal antibody
Formatmab
Target NameCCN5
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CCN5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0753-Ag-1Recombinant multi-species CCN5/ CT58/ CTGF-L protein
    ORF Viral VectorpGMLV000733house mouse Ccn5 Lentivirus plasmid
    ORF Viral VectorvGMLV000733house mouse Ccn5 Lentivirus particle


    Target information

    Target IDGM-SE0753
    Target NameCCN5
    Gene ID8839,22403,29576,717872,610928,101091930,534658,100070779
    Gene Symbol and SynonymsCCN5,Crgr4,CT58,CTGF-L,Ctgfl,Rcop1,WISP2
    Uniprot AccessionO76076,Q9JHC6
    Uniprot Entry NameCCN5_HUMAN,CCN5_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000064205
    Target ClassificationN/A

    The target: CCN5, gene name: CCN5, also named as CT58, CTGF-L, WISP2. This gene encodes a member of the WNT1 inducible signaling pathway (WISP) protein subfamily, which belongs to the connective tissue growth factor (CTGF) family. WNT1 is a member of a family of cysteine-rich, glycosylated signaling proteins that mediate diverse developmental processes. The CTGF family members are characterized by four conserved cysteine-rich domains: insulin-like growth factor-binding domain, von Willebrand factor type C module, thrombospondin domain and C-terminal cystine knot-like (CT) domain. The encoded protein lacks the CT domain which is implicated in dimerization and heparin binding. It is 72% identical to the mouse protein at the amino acid level. This gene may be downstream in the WNT1 signaling pathway that is relevant to malignant transformation. Its expression in colon tumors is reduced while the other two WISP members are overexpressed in colon tumors. It is expressed at high levels in bone tissue, and may play an important role in modulating bone turnover. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.